source
- Alzheimer researcher Betty Tijms urges broader view beyond amyloid and tauBetty Tijms, head of science at the Alzheimer Center Amsterdam, says it is time to stop treating Alzheimer’s as a single disease. For more than a century, research has focused on two proteins, amy…
- FDA issues first AI-focused cGMP warning letter, flagging oversight gaps for manufacturersThe FDA has issued its first warning letter that explicitly addresses the use of artificial intelligence in pharmaceutical manufacturing, targeting Purolea Cosmetics Lab. The letter cites AI‑gener…